About this journal
Aims and scope
European Clinical Respiratory Journal (ECRJ) is a peer-reviewed international open access journal that publishes studies within the area of respiratory diseases.
ECRJ focuses on the immunology and pathophysiology of the respiratory system, providing an understanding of disease mechanisms and how the body combats these diseases. Respiratory disease is a public health problem with several hundreds of millions currently suffering from chronic respiratory diseases, creating a large burden on both society and on the healthcare system. According to the World Health Organization (WHO), respiratory disease, including lower respiratory infections, COPD and lung cancers, accounts for 7 million deaths annually worldwide.
The journal publishes under two sections, the scientific section that focuses on clinical aspects and scientific data of respiratory disease, and the educational section that focuses on papers that aim to translate the scientific data into relevant clinical recommendations. The type of work considered in each of these sections includes (but not limited to) :
Scientific Section
- Epidemiology of disease and preventive strategies
- Pathophysiological and immunological mechanisms of respiratory diseases
- Identification of potential future treatment targets and novel treatments of respiratory diseases
- Clinical trials including randomized, placebo controlled and observational "real life" clinical trials
- Clinical aspects of respiratory disease including systemic involvement and comorbidities
- Improved diagnostic and research methods, including imaging techniques, physiological tests, sampling techniques and biomarkers
- Occupational and environment related lung disease
- Progress in smoking intervention and cessation methods
- Disease and management-related issues, including self-management
- Updates on the status of and advances in specific disease areas, including allergy, asthma, ARDS, COPD, ILD, Cystic Fibrosis, bronchiectasis, respiratory infectious diseases, tuberculosis, lung cancer, and sleep-disordered breathing morbidity
Educational Section
- Treatment guidelines overview
- Diagnostic procedures and recommendations
- Literature reviews and meta-analyses
- Case presentations and reviews of the literature
- Letter to the editor
- Expert opinions, meetings and symposium proceedings
The journal operates a double-anonymized peer review policy.
Journal metrics
Usage
- 78K annual downloads/views
Citation metrics
- 1.8 (2023) Impact Factor
- 1.9 (2023) 5 year IF
- 3.8 (2023) CiteScore (Scopus)
- Q2 CiteScore Best Quartile
- 0.727 (2023) SNIP
- 0.672 (2023) SJR
Speed/acceptance
- 33 days avg. from submission to first decision
- 44 days avg. from submission to first post-review decision
- 10 days avg. from acceptance to online publication
- 37% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.
For more details, please read the Author Services guide to understanding journal metrics.
Journal metrics in brief
Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).
- Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.
Citation Metrics
- Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
- Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
- 5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
- CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
- CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
- SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
- SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.
Speed/acceptance
- From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
- From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
- From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
- Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.
For more details on the data above, please read the Author Services guide to understanding journal metrics.
*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus
Editorial board
Editor-in-Chief
Vasiliki Panou, MD, phD, Clinical Associate Professor
Dept. of Respiratory Medicine, Odense University Hospital, Odense, Denmark
& Dept. of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark
Deputy Chief Editor
Professor Vibeke Backer, MD, DMSc
University of South Denmark and Rigshospitalet, Copenhagen, Denmark
Associate Editors (for each area below)
ASTHMA, RHINITIS AND ALLERGY
Associate Editor responsible for this area:
Professor Charlotte S. Ulrik, MD, DMSc
University of Copenhagen and Amager-Hvidovre Hospital, Hvidovre, Denmark
MECHANICS OF AIRWAY DISEASES
Associate Editor responsible for this area:
Hans Jürgen Hoffmann, PhD
CLINICAL IMMUNOLOGY
Associate Editor responsible for this area:
Aarhus University, Denmark
Associate Editor responsible for this area:
Professor Jann Mortensen, MD, DMSc
University of Copenhagen and Rigshospitalet, Copenhagen East, Denmark
PULMO-CARDIOLOGY [Interplay between lungs and heart]
Associate Editor responsible for this area:
Dr Hans Henrik Lawaetz Schultz MD, PhD
Dept of Cardiology, section for lung transplantation, Rigshospitalet, Copenhagen
RESPIRATORY MEDICINE/PULMONOLOGY
Associate Professor, Pradeesh Sivapalan, MD, PhD
University of Copenhagen and Herlev-Gentofte Hospital, Hellerup, Denmark
COPD, NON-INVASIVE VENTILATION
Associate Editor responsible for this area:
RCT leader Pradeesh Sivapalan, MD, PhD
University of Copenhagen and Herlev-Gentofte Hospital, Hellerup, Denmark
INTERSTITIAL LUNG DISEASES
Associate Editors responsible for this area:
Professor Elisabeth Bendstrup, MD, PhD
University of Aarhus and Aarhus Universitetshospital, Skejby, Denmark
Professor Jesper Rømhild Davidsen, PhD
Odense University Hospital, and University of Southern Denmark, Denmark
RESPIRATORY EPIDEMIOLOGY
Associate Editor responsible for this area:
Post doc Yunus Çolak, MD, PhD
Copenhagen University Hospital Herlev-Gentofte Hospital, Hellerup, Denmark
LUNG INFECTIONS
Associate Editor responsible for this area:
Associate Professor Zitta Fiorella Barrella, MD, PhD
University of Copenhagen and North Zealand Hospital, Hillerød, Denmark
LUNG CANCER and INVASIVE TECHNIQUES
Professor Uffe Christian Heitmann Bødtger, MD, PhD
University of Southern Denmark and Roskilde Hospital, Roskilde, Denmark
TREATMENT OF HYPOXEMIA AND HYPERCAPNIA
Associate editor responsible for this area
Associate Professor Ulla Møller Weinreich, MD, PhD
Aalborg University Hospital, Aalborg, Denmark
PEDIATRIC LUNG DISEASES
Associate Editor responsible for this area:
Editor: Not assigned
PEDIATRIC PULMONOLOGY
Kim G. Neilsen
Rigshospitalet, Copenhagen
SLEEPING DISORDERS
Associate Editor responsible for this area:
Professor Karl Franklin, MD, PhD
Umeå University and Umeå University Hospital, Umeå, Sweden
DIAGNOSTIC IMAGING in RESPIRATORY MEDICINE
Associate Editor responsible for this area:
Professor Christian B. Laursen, MD, PhD
University of Southern Denmark and Odense University Hospital, Odense, Denmark
Editor ”Emeritus”
Professor Leif Bjermer - FOUU, University Hospital, Lund, Sweden
Abstracting and indexing
European Clinical Respiratory Journal is indexed/tracked/covered by the following services:
Directory of Open Access Journals (DOAJ)
EMBASE (Elsevier)
Emerging Sources Citation Index (Clarivate Analytics)
Open Access Journals Integrated Service System Project (GoOA)
PubMed (NLM)
PubMed Central (NLM)
Scopus
The bibliographic reference lists in all articles of European Clinical Respiratory Journal are included in the Open Citations Corpus.
Open access
European Clinical Respiratory Journal is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
- Increase the discoverability and readership of your article
- Make an impact and reach new readers, not just those with easy access to a research library
- Freely share your work with anyone, anywhere
- Comply with funding mandates and meet the requirements of your institution, employer or funder
- Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Use our APC finder to calculate your article publishing charge
1 issue per year
the Nordic Respiratory Societies and our publisher Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, the Nordic Respiratory Societies and our publisher Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by the Nordic Respiratory Societies and our publisher Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. the Nordic Respiratory Societies and our publisher Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window) Instructions for authors